Lab News
BD sees Q1 revenues up 26% as COVID-19 testing drives sales
January 13, 2021 -- Becton Dickinson (BD) is projecting revenues for its fiscal first quarter to grow 26% as sales of COVID-19 testing products hit $865 million -- contributing 20 percentage points to revenue growth for the quarter.
Delfi raises $100M to develop liquid biopsy for multiple cancers
January 13, 2021 -- Delfi Diagnostics has raised $100 million in a fundraising round with existing and new investors to help the company fund development of its liquid biopsy technology to detect multiple types of cancer.
Falling lung cancer rates drive cancer decline in U.S. over past 2 decades
January 12, 2021 -- The death rate for people who have lung cancer in the U.S. continued to drop in 2020, according to a January 12 report from the American Cancer Society. The drop has contributed to a decline in cancer mortality of almost one-third in the last 20 years.  Discuss
Freenome touts ASCO study of blood test for colorectal adenomas
January 12, 2021 -- Freenome is highlighting the results of a clinical study of its blood test for detecting colorectal advanced adenomas to be presented at the American Society of Clinical Oncology's (ASCO) Gastrointestinal Cancers Symposium, January 15-17.
COVID-19 pandemic accelerates adoption of diagnostic testing at point of care
January 11, 2021 -- Out of a very bad year where the COVID-19 pandemic brought the world to its knees has come some good, investors say. Point-of-care diagnostics tests are flourishing, according to panelists at the Biotech Showcase investor conference, held online from January 11-15.  Discuss
Abbott wins FDA nod for blood test to diagnose concussion
January 11, 2021 -- Abbott has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a rapid blood test to assist with the diagnosis of concussions and other mild traumatic brain injuries.
Grail to collaborate with top companies for MRD detection
January 11, 2021 -- Cancer diagnostics startup Grail has announced collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to evaluate the ability of Grail's methylation-based platform to detect minimal residual disease (MRD).
FDA warns labs that SARS-CoV-2 variant could cause false-negative test results
January 8, 2021 -- The U.S. Food and Drug Administration (FDA) has sent an alert to clinical laboratory staff and healthcare providers regarding the potential effect of SARS-CoV-2 viral mutations causing false-negative results on diagnostic tests.  Discuss
Diagnostics growth drives Hologic's Q1 results higher
January 8, 2021 -- Strong growth in its molecular diagnostics business -- with revenues almost tripling due to the COVID-19 pandemic -- helped drive first-quarter preliminary financial results for Hologic.
Everlywell, Gingko Bioworks to distribute COVID-19 antigen test
January 8, 2021 -- Everlywell has signed an agreement with Ginkgo Bioworks to distribute Access Bio's CareStart COVID-19 antigen test to workplaces, clinics, schools, government offices, and health plans.
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets